Tracy Curley, the CEO of iSpecimen, an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, discusses the iSpecimen platform, the importance of just-in-time biobanking and what’s up next for the industry.
Tracy is an experienced, results-oriented business builder focused on leading iSpecimen’s vision for progressive financial performance, expansion and growth in today’s dynamic healthcare and biotechnology research markets.
Tracy brings three decades of experience in public accounting and corporate finance for both publicly traded companies and emerging companies like iSpecimen. Before joining iSpecimen, Tracy served as a partner at CohnReznick LLP, a national accounting firm, where she led the creation and development of an emerging markets commercial audit practice team focused on recruiting and providing audit services to private and public emerging growth companies in the technology and life sciences industries. Earlier, and as a partner at Marcum LLP, a national accounting firm, Tracy led the northeast regional high-tech practice for the firm with a focus on expanding the client base to provide a full range of accounting, tax and advisory services for private and public emerging growth companies in high tech industries such as technology, life sciences and advanced manufacturing. Tracy has also served as a partner at Moody, Famiglietti & Andronico, LLP (MFA), a proactive, Boston-based consulting firm with national and global reach, where she led the creation and development of a public company audit practice focused on recruiting and providing audit services to public emerging growth companies.
Tracy received her Master of Accountancy and Bachelor of Science in Business Administration with a concentration in accounting from Kansas State University. She also attended the United States Military Academy. She is a certified public accountant licensed in the Commonwealth of Massachusetts.